Intermediate risk Myelofibrosis
Intermediate Risk Myelofibrosis: What You Need to Know
Intermediate risk myelofibrosis (also known as MF) is a rare and serious type of bone marrow disorder. It is an acquired disorder primarily diagnosed in adults and can only be managed, not cured. The primary symptom of MF is the enlargement of the spleen.
Symptoms of intermediate risk myelofibrosis include:
- Fever
- Fatigue
- Weight loss
- Night sweats
- Itching
- Alterations in blood cell counts
- Bone pain
- Fluid retention
- Enlarged lymph nodes
Diagnosis of intermediate risk myelofibrosis is based on a complete medical history and physical examination. This is followed by lab tests, X-ray, MRI, CT scan, bone marrow biopsy, and bone marrow aspiration.
Treatment for intermediate risk myelofibrosis is focused on controlling symptoms. This may include pain medicines, blood transfusions, and medications to reduce spleen size. Other treatments include physical therapy, supportive care, and treatments to reduce bone marrow damage, such as chemotherapy and medication.
Being diagnosed with intermediate risk myelofibrosis can be a difficult time. It is important to get support from family and friends and seek medical advice from a healthcare professional. It is also important to find a specialist who is knowledgeable about MF – they may be able to give more information about the condition and appropriate treatments.